source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[individual]	characteristics[biological replicate]	technology type	assay name	comment[technical replicate]	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[collision energy]	factor value[Patient groups ]
PXD007962-sample-1	Homo sapiens	Urine	not available	not available	not available	female	Benign - ovarian related 	not available	1	proteomic profiling by mass spectrometry	run1	1	P3063_B_1_1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_B_1_1_1.raw	1	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Benign - ovarian related 
PXD007962-sample-1	Homo sapiens	Urine	not available	not available	not available	female	Benign - ovarian related 	not available	1	proteomic profiling by mass spectrometry	run2	1	P3063_B_1_1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_B_1_1_2.raw	2	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Benign - ovarian related 
PXD007962-sample-1	Homo sapiens	Urine	not available	not available	not available	female	Benign - ovarian related 	not available	1	proteomic profiling by mass spectrometry	run3	1	P3063_B_1_1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_B_1_1_3.raw	3	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Benign - ovarian related 
PXD007962-sample-1	Homo sapiens	Urine	not available	not available	not available	female	Benign - ovarian related 	not available	1	proteomic profiling by mass spectrometry	run4	1	P3063_B_1_1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_B_1_1_4.raw	4	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Benign - ovarian related 
PXD007962-sample-1	Homo sapiens	Urine	not available	not available	not available	female	Benign - ovarian related 	not available	1	proteomic profiling by mass spectrometry	run5	1	P3063_B_1_1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_B_1_1_5.raw	5	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Benign - ovarian related 
PXD007962-sample-2	Homo sapiens	Urine	not available	not available	not available	female	Serous Cancer Late	not available	1	proteomic profiling by mass spectrometry	run6	1	P3063_L_1_1_1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_L_1_1_1.raw	1	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Serous Cancer Late
PXD007962-sample-2	Homo sapiens	Urine	not available	not available	not available	female	Serous Cancer Late	not available	1	proteomic profiling by mass spectrometry	run7	1	P3063_L_1_1_2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_L_1_1_2.raw	2	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Serous Cancer Late
PXD007962-sample-2	Homo sapiens	Urine	not available	not available	not available	female	Serous Cancer Late	not available	1	proteomic profiling by mass spectrometry	run8	1	P3063_L_1_1_3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_L_1_1_3.raw	3	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Serous Cancer Late
PXD007962-sample-2	Homo sapiens	Urine	not available	not available	not available	female	Serous Cancer Late	not available	1	proteomic profiling by mass spectrometry	run9	1	P3063_L_1_1_4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_L_1_1_4.raw	4	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Serous Cancer Late
PXD007962-sample-2	Homo sapiens	Urine	not available	not available	not available	female	Serous Cancer Late	not available	1	proteomic profiling by mass spectrometry	run10	1	P3063_L_1_1_5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/02/PXD007962/P3063_L_1_1_5.raw	5	NT=label free sample;AC=MS:1002038	NT=Q Exactive;AC=MS:1001911	NT=Trypsin;AC=MS:1001251	NT=Carbamidomethyl;MT=Fixed;TA=C;AC=UNIMOD:4	NT=Acetyl;MT=Variable;TA=N-term;AC=UNIMOD:1	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	HCD	4.5 ppm	20 ppm	27% NCE	Serous Cancer Late
